E-ISSN: 1308-5263
Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia [Turk J Hematol]
Turk J Hematol. 2022; 39(3): 204-205 | DOI: 10.4274/tjh.galenos.2022.2022.0247  

Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia

Susan Branford
Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, Australia



Kronik Myeloid Lösemi Tedavisine Yanıt Tahmininde Başlangıç BCR: : ABL1 Düşüş Hızı

Susan Branford
Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, Australia



Susan Branford. Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia. Turk J Hematol. 2022; 39(3): 204-205

Corresponding Author: Susan Branford, Australia


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar